Cargando…

NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway

Hepatocellular carcinoma (HCC) is one of the most prevalent and aggressive malignant tumors. The involvement of N-myc (and STAT) interactor (NMI) and its possible functional mechanisms in HCC progression still remain to be elucidated. In this study, we found that NMI was overexpressed in metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jing, Dong, Qiong-Zhu, Zhong, Fan, Cai, Li-Li, Qin, Zhao-Yu, Liu, Yang, Lin, Cheng-Zhao, Qin, Lun-Xiu, He, Fu-Chu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355334/ https://www.ncbi.nlm.nih.gov/pubmed/28077802 http://dx.doi.org/10.18632/oncotarget.14556

Ejemplares similares

NMI and EMT
por: Samant, Rajeev S., et al.
Publicado: (2014)

Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas
por: Wang, Jingshu, et al.
Publicado: (2017)

NMI mediates transcription-independent ARF regulation in response to cellular stresses
por: Li, Zengpeng, et al.
Publicado: (2012)

NMI: a potential biomarker for tumor prognosis and immunotherapy
por: He, Teng, et al.
Publicado: (2022)

BDKRB2 GENE -9/+9 POLYMORPHISM AND SWIMMING PERFORMANCE
por: Grenda, A., et al.
Publicado: (2014)

When Measurements Meet Blockchain: On Behalf of an Inter-NMI Network †
por: Moni, Mahbuba, et al.
Publicado: (2021)

Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway
por: Wang, Mu-Ru, et al.
Publicado: (2020)

NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer
por: Feng, Xu, et al.
Publicado: (2017)

Facile Amide Bond Formation with TCFH–NMI in an Organic Laboratory Course
por: M. Baldwin, Oliver W., et al.
Publicado: (2022)

NMI and IFP35 serve as proinflammatory DAMPs during cellular infection and injury
por: Xiahou, Zhikai, et al.
Publicado: (2017)

HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway
por: Xu, Yanan, et al.
Publicado: (2023)

OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway
por: Li, Hua, et al.
Publicado: (2016)

Hypoxia Activates Notch4 via ERK/JNK/P38 MAPK Signaling Pathways to Promote Lung Adenocarcinoma Progression and Metastasis
por: Li, Xiaochen, et al.
Publicado: (2021)

HBV precore G1896A mutation promotes growth of hepatocellular carcinoma cells by activating ERK/MAPK pathway
por: Zhao, Baoxin, et al.
Publicado: (2023)

The Bdkrb2 gene family provides a novel view of viviparity adaptation in Sebastes schlegelii
por: Niu, Jingjing, et al.
Publicado: (2021)

GPR27 Regulates Hepatocellular Carcinoma Progression via MAPK/ERK Pathway
por: Wang, Hongxv, et al.
Publicado: (2022)

Network programmability with YANG: the structure of network automation with YANG, NETCONF, RESTCONF, and gNMI
por: Claise, Benoit, et al.
Publicado: (2019)

BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
por: Moon, Hyuk, et al.
Publicado: (2021)

Genetic effects of BDKRB2 and KNG1 on deep venous thrombosis after orthopedic surgery and the potential mediator
por: Wang, Qingfeng, et al.
Publicado: (2018)

Serum bradykinin levels as a diagnostic marker in cervical cancer with a potential mechanism to promote VEGF expression via BDKRB2
por: Zhou, Ying, et al.
Publicado: (2019)

Genomic Aberrations in the HTPAP Promoter Affect Tumor Metastasis and Clinical Prognosis of Hepatocellular Carcinoma
por: Wu, Jin-Cai, et al.
Publicado: (2014)

HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma
por: Wang, Wei-Min, et al.
Publicado: (2017)

IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer
por: Jiang, J, et al.
Publicado: (2011)

BDKRB2 +9/−9 Polymorphism Is Associated with Higher Risk for Diabetes Mellitus in the Brazilian General Population
por: Alvim, Rafael de Oliveira, et al.
Publicado: (2012)

miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
por: Xiao, Shuai, et al.
Publicado: (2018)

TRAF3IP3 promotes glioma progression through the ERK signaling pathway
por: Lin, Qi, et al.
Publicado: (2022)

Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression
por: Li, Qiang, et al.
Publicado: (2020)

Downregulation of THRSP Promotes Hepatocellular Carcinoma Progression by Triggering ZEB1 Transcription in an ERK-dependent Manner
por: Hu, Qiong, et al.
Publicado: (2021)

LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway
por: Zhang, Quan, et al.
Publicado: (2020)

Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways
por: Yu, Ze-Yuan, et al.
Publicado: (2020)

Suitable reference genes for real-time PCR in human HBV-related hepatocellular carcinoma with different clinical prognoses
por: Fu, Li-Yun, et al.
Publicado: (2009)

Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors
por: Alsheikh, Heba Allah M., et al.
Publicado: (2021)

Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
por: Xiao, Shuai, et al.
Publicado: (2021)

CK-3, A Novel Methsulfonyl Pyridine Derivative, Suppresses Hepatocellular Carcinoma Proliferation and Invasion by Blocking the PI3K/AKT/mTOR and MAPK/ERK Pathways
por: Wu, Qiong, et al.
Publicado: (2021)

Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development
por: Deng, Rong, et al.
Publicado: (2015)

Downregulation of MicroRNA-222 Reduces Insulin Resistance in Rats with PCOS by Inhibiting Activation of the MAPK/ERK Pathway via Pten
por: Ye, Hong, et al.
Publicado: (2020)

Exercise Induced-Cytokines Response in Marathon Runners: Role of ACE I/D and BDKRB2 +9/-9 Polymorphisms
por: Sierra, Ana Paula Renno, et al.
Publicado: (2022)

PICALM exerts a role in promoting CRC progression through ERK/MAPK signaling pathway
por: Zhang, Xitao, et al.
Publicado: (2022)

BRF1 ameliorates LPS-induced inflammation through autophagy crosstalking with MAPK/ERK signaling
por: Xie, Weiwei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aibt1g925smq6i81cgb3gkski5